Nuclear factor-κB activation is associated with glutamate-evoked tissue transglutaminase up-regulation in primary astrocyte cultures

Journal of Neuroscience Research

Volumn 82, Issue 6, 2005, Pages 858-865

  Caccamo, Daniela ^a   Campisi, Agata ^b   Currò, Monica ^a   Aguennouz, Mohammed ^a   Li Volti, Giovanni ^b   Avola, Roberto ^b   Ientile, Riccardo ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Astroglial cells; Glutamate; NF B inhibitor; Tissue transglutaminase

Indexed keywords

CELL EXTRACT; GLUTAMIC ACID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN P50; PROTEIN SUBUNIT; SN 50; SN 50M; SYNAPTOTAGMIN; UNCLASSIFIED DRUG; ENZYME INHIBITOR; MESSENGER RNA; NF KAPPA B KINASE; NF-KAPPA B KINASE; PEPTIDE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; EVOKED RESPONSE; GEL MOBILITY SHIFT ASSAY; LIGHT CHAIN; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; REDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; METHODOLOGY; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BLOTTING, WESTERN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; ENZYME INHIBITORS; GLUTAMIC ACID; PEPTIDES; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSGLUTAMINASES; UP-REGULATION;

EID: 28544451599     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20683     Document Type: Article

References (40)

1. Akama KT, Albanese C, Pestell RG, Van Eldik LJ. 1998. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NF-κB-dependent mechanism. Proc Natl Acad Sci U S A 95:5795-5800.
2. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. 2000. In vivo antigen challenge in celiac disease identifies a single transglutaminase- modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 6:337-342.
3. Bailey CD, Johnson GV. 2005. Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanisms. J Neurochem 92:83-92.
4. Caccamo D, Campisi A, Marini H, Adamo E, Squadrito F, Ientile R. 2005. Glutamate promotes NF-ê pathway in primary astrocytes: protective effects of IRFI 016, a synthetic vitamin E analogue. Exp Neurol 193:377-383.
5. Campisi A, Caccamo D, Raciti G, Cannavò G, Macaione V, Currò M, Macaione S, Vanella A, Ientile R. 2003. Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells. Brain Res 978:24-30.
6. Campisi A, Caccamo D, Li Volti G, Currò M, Parisi G, Avola R, Vanella A, Ientile R. 2004. Glutamate-evoked redox state alterations are involved in tissue transglutaminase up-regulation in primary astrocyte cultures. FEBS Lett 578:80-84.
7. Chen CJ, Liao SL, Kuo JS. 2000. Gliotoxic action of glutamate on cultured astrocytes. J Neurochem 75:1557-1565.
8. Citron BA, Suo Z, SantaCruz K, Davies PJ, Qin F, Festoff BW. 2002. Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration. Neurochem Int 40:69-78.
9. Festoff BW, Suo Z, Citron BA. 2003. Prospects for the pharmacotherapy of amyotrophic lateral sclerosis: old strategies and new paradigms for the third millennium. CNS Drug 17:699-717.
10. Fesus L, Piacentini M. 2002. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27:534-539.
11. Fridmacher V, Kaltschmidt B, Goudeau B, Ndiaye D, Rossi F M, Pfeiffer J, Kaltschmidt C, Israel A, Memet S. 2003. Forebrain-specific neuronal inhibition of nuclear factor-kappaB activity leads to loss of neuroprotection. J Neurosci 23:9403-9408.
12. Fujita K, Shibayama K, Yamauchi M, Kato T, Ando M, Takahashi H, Iritani K, Yoshimoto N, Nagata Y. 1998. Alteration of enzymatic activities implicating neuronal degeneration in the spinal cord of the motor neuron degeneration mouse during postnatal development. Neurochem Res 23:557-562.
13. Grimm S, Baeuerle PA. 1993. The inducible transcription factor NF-κ B: structure-function relationship of its protein subunits. Biochem J 290: 297-308.
14. Gu Z, Cain L, Werrbach-Perez K, Perez-Polo JR. 2000. Differential alterations of NF-κB to oxidative stress in primary basal forebrain cultures. Int J Dev Neurosci 18:185-192.
15. Had-Aissouni L, Re DB, Nieoullon A, Kerkerian-Le Goff L. 2002. Importance of astrocytic inactivation of synaptically released glutamate for cell survival in the central nervous system-are astrocytes vulnerable to low intracellular glutamate concentrations? J Physiol (Paris) 96:317-322.
16. Ientile R, Caccamo D, Macaione V, Torre V, Macaione S. 2002. NMDA-evoked excitotoxicity increases tissue transglutaminase in cerebellar granule cells. Neuroscience 115:723-729.
17. Ientile R, Caccamo D, Marciano MC, Curro M, Mannucci C, Campisi A, Calapai G. 2004. Transglutaminase activity and transglutaminase mRNA transcripts in gerbil brain ischemia. Neurosci Lett 363:173-177.
18. Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM. 2003. Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and denmentia with Lewy bodies. Proc Natl Acad Sci U S A 100:2047-2052.
19. Kim SY, Jeong EJ, Steinert PM. 2002. IFN-gamma induces transglutaminase 2 expression in rat small intestinal cells. J Interferon Cytokine Res 22:677-682.
20. Kuncio GS, Tsyganskaya M, Zhu J, Liu SL, Nagy L, Thomazy V, Davies PJ, Zern MA. 1998. TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. Am J Physiol 274:G240-G245.
21. Lam AG, Koppal T, Akama KT, Guo L, Craft JM, Samy B, Schavocky JP, Watterson DM, Van Eldik LJ. 2001. Mechanism of glial activation by S100B: involvement of the transcription factor NF-κB. Neurobiol Aging 22:765-772.
22. Lee J, Kim YS, Choi DH, Bang MS, Han TR, Job TH, Kim SY. 2004. Transglutaminase 2 induces nuclear factor-κB activation via a novel pathway in BV-2 microglia. J Biol Chem 279:53725-53735.
23. Lee ZW, Kwon SM, Kim SW, Yi SJ, Kim YM, Ha KS. 2003. Activation of in situ tissue transglutaminase by intracellular reactive oxygen species. Biochem Biophys Res Commun 305:33-640.
24. Lesort M, Attanavanich K, Zhang J, Johnson GV. 1998. Distinct nuclear localization and activity of tissue transglutaminase. J Biol Chem 273: 11991-11994.
25. Lesort M, Tucholski J, Miller ML, Johnson GV. 2000. Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog Neurobiol 61:439-463.
26. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. 1995. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270:14255-14258.
27. Lorand L, Graham RM. 2003. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140-156.
28. Mastroberardino PG, Iannicola C, Nardacci R, Bernassola F, De Laurenzi V, Melino G, Moreno S, Pavone F, Oliverio S, Fesus L, Piacentini M. 2002. 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ 9:873-880.
29. Mattson MP. 2003. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol Med 3:65-94.
30. Matute C, Alberdi E, Ibarretxe G, Sanchez-Gomez MV. 2002. Excitotoxicity in glial cells. Eur J Pharmacol 447:239-246.
31. Mirza A, Liu SL, Frizell E, Zhu J, Maddukuri S, Martinez J, Davies P, Schwarting R, Norton P, Zern MA. 1997. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-KB. Am J Physiol 272:G281-G288.
32. Naumann M, Scheidereit C. 1994. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J 13:4597-4607.
33. O'Neill LA, Kaltschmidt C. 1997. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20:252-258.
34. Ré DB, Boucraut J, Samuel D, Birman S, Kerkerian-Le Goff L, Had-Aissouni L. 2003. Glutamate transport alteration triggers differentiation-state selective oxidative death of cultured astrocytes: a mechanism different from excitotoxicity depending on intracellular GSH contents. J Neurochem 85:1159-1170.
35. Rosenberger J, Petrovics G, Buzas B. 2001. Oxidative stress induces pro-orphanin FQ and pro-enkephalin gene expression in astrocytes through p38 and ERK-MAP kinases and NF-κB. J Neurochem 79:35-44.
36. Sandhu JK, Pandey S, Ribecco-Lutkiewicz M, Monette R, Borowy-Borowski H, Walker PR, Sikorska M. 2003. Molecular mechanisms of glutamate neurotoxicity in mixed cultures of NT2-derived neurons and astrocytes: protective effects of coenzyme Q10. J Neurosci Res 72:691-703.
37. Schreck R, Albermann K, Baeuerle PA. 1991. Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic Res Commun 17:221-237.
38. Singer SM, Zainelli GM, Norlund MA, Lee JM, Muma NA. 2002. Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease. Neurochem Int 40:17-30.
39. 2+ reperfusion injury of cultured astrocytes: roles of reactive oxygen species and NF-κB activation. Eur J Neurosci 11:4204-4212.
40. Zainelli GM, Ross CA, Troncoso JC, Muma NA. 2003. Transglutaminase cross-links in intranuclear inclusions in Huntington disease. J Neuropathol Exp Neurol 62:14-24.